Humans Myocarditis Cardio-oncology Acid-alpha-glucosidase Immune checkpoint inhibitors Adjudication Anti-synthetase syndrome Polymyositis Adeno-associated vector Muscle Anti-IgE IgG Agalsidase Active Middle Aged Biomarqueurs AAV antibody Autoimmune diseases Gene therapy AAV Lysosomal storage diseases Anti-Mi2 DM AAV humoral immunity COVID-19 Skeletal muscle Dermatomyositis Anémie hémolytique Antiphospholipid syndrome Assisted communication devices Animals Myopathy AAV vectors Auto-antibodies Female Prognosis Aldosterone Anti-MDA5 autoantibodies Data integration Anti-agalsidase antibodies Autoantibody Myositis Amyotrophy Adolescence Antisynthetase syndrome Outcome measures Adverse drug reactions Inflammation Mass cytometry Anti-drug antibodies Machine learning Inflammatory myopathy Auto-immunité Aldostérone Fabry disease Pharmacology Acute Kidney Injury/epidemiology/etiology Male Inborn errors of metabolism Inclusion body myositis Idiopathic inflammatory myopathies AAV vector Anti‐mitochondrial antibodies Interstitial lung disease IBM Analyses multidimensionnelles Anticorps anti-agalsidase Biopsy Autoantibodies Multidisciplinarity Dependovirus/genetics/immunology Anti-interleukin-6 Interferon Bioelectrical impedance analysis Amyotrophic lateral sclerosis Immunotherapy Sphingosine-1-phosphate Biomarkers Antisynthetase Adeno-associated virus Adult Cytokines Antibodies Cancer B-lymphocyte Anticorps spécifique des myosites Adeno-associated virus vector Biomarker Antibody responses Auto‐antibodies Antisynthétase IMNM Abnormal movement B cell homeostasis Deep immune profiling Myositis and muscle disease Aged Case reports Arthritis Systems biology Autoimmunity